Home/Filings/4/0001567619-21-020581
4//SEC Filing

Kristal Robert Eugene 4

Accession 0001567619-21-020581

CIK 0001505497other

Filed

Nov 15, 7:00 PM ET

Accepted

Nov 16, 4:24 PM ET

Size

5.4 KB

Accession

0001567619-21-020581

Insider Transaction Report

Form 4
Period: 2021-11-04
Kristal Robert Eugene
Chief Financial Officer
Transactions
  • Award

    Stock Option

    2021-11-04+10,49010,490 total
    Exercise: $13.50Exp: 2031-11-04Common Stock (10,490 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable in eight nearly-equal quarterly installments beginning on February 4, 2022 and continuing every three months thereafter until fully vested.

Documents

1 file

Issuer

BioRestorative Therapies, Inc.

CIK 0001505497

Entity typeother

Related Parties

1
  • filerCIK 0001893955

Filing Metadata

Form type
4
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 4:24 PM ET
Size
5.4 KB